Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical Trial

Michael Brownstein, Stephanie Lowenhaupt, Patricia M. Conlon et al.|Journal of Clinical Medicine|2020

Cited by 32